Benha University
bu.edu.egTotal trials
317
Active
56
Phase 3
29
Total enrollment
38,018
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 29 of 29 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Bupivacaine | — | — | 5 | ||||
| Dexmedetomidine | — | — | — | 12 | |||
| Melatonin | — | — | — | — | 2 | ||
| TNF-α Inhibitor | — | — | — | — | — | 1 | |
| Bupivacaine and Dexmedetomidine | — | — | — | — | — | 1 | |
| Fentanyl | — | — | — | 4 | |||
| Oral intake of sildosin | — | — | — | — | — | 1 | |
| Hyaluronidase | — | — | — | — | 2 | ||
| Dexamethasone | — | — | — | — | 3 | ||
| Botulinum toxin type A | — | — | — | — | 2 | ||
| Vitamin B Complex | — | — | — | — | — | 1 | |
| vitamin C | — | — | — | — | — | 1 | |
| Hyaluronic acid | — | — | — | — | — | 1 | |
| Midazolam plus ultrasound-guided spinal anesthesia | — | — | — | — | — | 1 | |
| Melatonin 5 mg | — | — | — | — | — | 1 | |
| Melatonin 10 mg | — | — | — | — | — | 1 | |
| Platelet-Rich Plasma | — | — | — | — | — | 1 | |
| Intravesical Botulinum Toxin | — | — | — | — | — | 1 | |
| Articaine | — | — | — | — | — | 1 | |
| Dexamethasone and dexmedetomidine | — | — | — | — | — | 1 | |
| Palmitoylethanolamide | — | — | — | — | — | 1 | |
| Ibuprofen | — | — | — | — | — | 1 | |
| Calcium and Vitamin D Supplementation | — | — | — | — | — | 1 | |
| frusemide | — | — | — | — | — | 1 | |
| Caudal Bupivacaine | — | — | — | — | — | 1 | |
| Caudal Dexmedetomidine | — | — | — | — | — | 1 | |
| Sedation with Midazolam, Fentanyl, and Propofol | — | — | — | — | — | 1 | |
| Bacillus clausii | — | — | — | — | — | 1 | |
| Haloperidol | — | — | — | — | — | 1 |
Next readouts
- 2024-08-01
- 2025-07
- 2025-09-01
- 2025-11
- 2025-12-15
- 2026-01
- 2026-03
- 2026-03-01
- 2026-04-10
- 2026-04-15
Top conditions
- Infertility9
- Pain, Postoperative8
- Eyelid Diseases8
- COVID-197
- Cesarean Section Complications7
- Retinal Detachment5
- Postoperative Pain5
- Cataract4
Frequently asked questions about Benha University
- How many clinical trials does Benha University have on ClinicalTrials.gov?
- Benha University is listed as the lead sponsor on 317 clinical trials in ClinicalTrials.gov, 56 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Benha University's trials are in Phase 3?
- 29 of Benha University's trials are in Phase 3, spread across 29 active drug programs.
- What therapeutic areas does Benha University focus on?
- Benha University's most-studied conditions on ClinicalTrials.gov are Infertility, Pain, Postoperative, Eyelid Diseases, COVID-19, Cesarean Section Complications.
- When are Benha University's next clinical trial readouts?
- Benha University has 10 upcoming primary-completion readouts tracked here; the soonest is “Articaine Plus Dexmedetomidine in Supraclavicular Block”, expected around 2024-08-01.